Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors

作者：Ogino Jiro; Asanuma Hiroko; Sakurai Shinji; Matsuno Yoshihiro; Miyokawa Naoyuki; Yamashiro Katsushige; Fukazawa Yuichiro; Muraoka Shunji; Iwaki Yasuyuki; Kondo Nobuo; Hasegawa Tadashi^*

来源：Pathology International, 2010, 60(11): 707-713.

DOI：10.1111/j.1440-1827.2010.02585.x

• concordance
• gastrointestinal stromal tumor (GIST)
• KIT
• PDGFRA
• spindle cell tumor
• tissue microarray

We assessed the concordance among seven general pathologists with respect to histologic diagnosis and interpretation of c-kit proto-oncogene (KIT) and platelet-derived growth factor receptor alpha (PDGFRA) immunostaining of 36 cases of primary spindle-cell tumor, predominantly of the gastrointestinal tract, mesentery, and retroperitoneum, based on review of a tissue microarray (TMA) subjected to immunohistochemistry with antibodies to KIT/CD117, PDGFRA, vimentin, desmin, smooth muscle action, CD34, and S-100 protein. Tumors included 20 molecularly analyzed gastrointestinal stromal tumors (GISTs), 4 leiomyosarcomas, 4 schwannomas, 4 desmoid-type fibromatoses, and 4 solitary fibrous tumors. The mean overall concordance with original diagnosis for each histologic type was 91.1%, with a mean kappa value of 0.91. With respect to PDGFRA immunostaining, the four GISTs with PDGFRA mutation were interpreted as cytoplasm positive, but the 16 GISTs with c-kit mutation were interpreted as weak or positive. These results indicate that the overall concordance with original diagnosis in mesenchymal tumors with the use of immunohistochemical panels is high, despite the use of TMAs. To some extent, PDGFRA immunophenotyping may be useful in GISTs with PDGFRA mutation, but it was not highly reproducible or specific. Therefore, in KIT-negative or weakly positive GISTs, mutation analysis will be required.

• 出版日期2010-11